AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 133 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $32,000 | -42.9% | 10,959 | -23.9% | 0.00% | -33.3% |
Q2 2021 | $56,000 | +7.7% | 14,404 | -8.0% | 0.00% | 0.0% |
Q1 2021 | $52,000 | +15.6% | 15,663 | -2.2% | 0.00% | 0.0% |
Q4 2020 | $45,000 | +40.6% | 16,012 | +24.0% | 0.00% | 0.0% |
Q3 2020 | $32,000 | -77.0% | 12,912 | +26.4% | 0.00% | -78.6% |
Q2 2020 | $139,000 | +162.3% | 10,212 | -6.1% | 0.01% | +55.6% |
Q2 2019 | $53,000 | -41.8% | 10,877 | -1.7% | 0.01% | -35.7% |
Q1 2019 | $91,000 | – | 11,064 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alerce Investment Management, L.P. | 4,652,561 | $1,642,000 | 3.05% |
Orchard Capital Management, LLC | 251,826 | $89,000 | 0.03% |
Bayesian Capital Management, LP | 304,100 | $107,000 | 0.02% |
Icon Wealth Partners, LLC | 400,132 | $141,000 | 0.02% |
ACADIAN ASSET MANAGEMENT LLC | 7,339,043 | $2,592,000 | 0.01% |
Ergoteles LLC | 849,000 | $300,000 | 0.01% |
WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
HRT FINANCIAL LP | 1,103,737 | $389,000 | 0.00% |
Running Point Capital Advisors, LLC | 10,000 | $4,000 | 0.00% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 777,617 | $275,000 | 0.00% |